NTRA.NASDAQNatera, INC

Form 4: Natera Co-Founder Jonathan Sheena Sells Shares

Sentiment:

SEC Form 4 Filing


Jonathan Sheena, co-founder of Natera, Inc., sold shares of common stock on February 26, 2025, according to a Form 4 filing with the SEC.

Summary

  • On February 26, 2025, Jonathan Sheena, co-founder of Natera, Inc. (NTRA), sold multiple blocks of common stock.
  • The sales were executed at varying prices, ranging from approximately $155.66 to $162.64 per share.
  • The sales were conducted under Rule 10b5-1 trading plans adopted on December 12, 2023, and June 7, 2024.
  • Sheena sold shares directly and indirectly through the Caraluna 1 Trust and Caraluna 2 Trust.
  • Following the transactions, Sheena directly owns 260,789 shares and indirectly owns 43,282 shares through Caraluna 1 Trust and 43,282 shares through Caraluna 2 Trust.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to stock sales by a company insider. It doesn't inherently convey positive or negative sentiment.

Industry Context

Sales by company insiders are a common occurrence and are often related to personal financial planning. It is important to consider the overall context of insider transactions, including the company's performance and outlook.

Stakeholder Impact

  • The stock sale may have a minor impact on shareholder sentiment, depending on how the market interprets the insider's actions.

Key Dates

DateDescription
December 12, 2023Date of adoption of Rule 10b5-1 trading plan.
June 7, 2024Date of adoption of Rule 10b5-1 trading plan.
February 26, 2025Date of stock sale transactions.
February 28, 2025Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.